<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shrestha R</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>2763-2771</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9989732</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>77(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Community-acquired carbapenem-resistant Enterobacterales (CA-CRE) are an important threat.&lt;h4>Methods&lt;/h4>In CRACKLE-2, we defined patients with CA-CRE as admitted from home, without pre-existing conditions, and a positive culture within 48 h of admission. Healthcare-associated CRE (HA-CRE) were those with the lowest likelihood of community acquisition, not admitted from home and cultured &amp;gt;48 h after admission. Specific genetic markers in carbapenemase-producing Klebsiella pneumoniae were evaluated through random forest modelling.&lt;h4>Results&lt;/h4>CA-CRE and HA-CRE were detected in 83 (10%) and 208 (26%) of 807 patients. No significant differences were observed in bacterial species or strain type distribution. K. pneumoniae (204/291, 70%) was the most common CRE species, of these 184/204 (90%) were carbapenemase producers (CPKP). The top three genetic markers in random forest models were kpi_SA15, fimE, and kpfC. Of these, kpi_SA15 (which encodes a chaperone/usher system) was positively associated (OR 3.14, 95% CI 1.13-8.87, P = 0.026), and kpfC negatively associated (OR 0.21, 95% CI 0.05-0.72, P = 0.015) with CA-CPKP.&lt;h4>Conclusions&lt;/h4>Ten percent of CDC-defined CRE were CA. The true proportion of CA-CRE in hospitalized patients is likely lower as patients may have had unrecorded prior healthcare exposure. The kpi_SA15 operon was associated with the CA phenotype.</pubmed_abstract><journal>The Journal of antimicrobial chemotherapy</journal><pubmed_title>Characteristics of community-acquired carbapenem-resistant Enterobacterales.</pubmed_title><pmcid>PMC9989732</pmcid><funding_grant_id>R01 AI134637</funding_grant_id><funding_grant_id>UM1 AI104681</funding_grant_id><funding_grant_id>P01 AI152999</funding_grant_id><funding_grant_id>R01AI143910</funding_grant_id><funding_grant_id>UM1AI104681</funding_grant_id><funding_grant_id>R01 AI143910</funding_grant_id><funding_grant_id>K24 AI121296</funding_grant_id><funding_grant_id>R01 AI148342</funding_grant_id><funding_grant_id>T32GM086330</funding_grant_id><funding_grant_id>T32 GM086330</funding_grant_id><pubmed_authors>Huskins WC</pubmed_authors><pubmed_authors>Dinh A</pubmed_authors><pubmed_authors>Salata RA</pubmed_authors><pubmed_authors>Rydell KB</pubmed_authors><pubmed_authors>Revolinski S</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Hanson B</pubmed_authors><pubmed_authors>Herc E</pubmed_authors><pubmed_authors>Rudin SD</pubmed_authors><pubmed_authors>Hill C</pubmed_authors><pubmed_authors>Domitrovic TN</pubmed_authors><pubmed_authors>Patel R</pubmed_authors><pubmed_authors>Kaye KS</pubmed_authors><pubmed_authors>Mediavilla JR</pubmed_authors><pubmed_authors>Patel G</pubmed_authors><pubmed_authors>Evans S</pubmed_authors><pubmed_authors>Ostrowsky B</pubmed_authors><pubmed_authors>Fries BC</pubmed_authors><pubmed_authors>Doi Y</pubmed_authors><pubmed_authors>Shropshire W</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Cober E</pubmed_authors><pubmed_authors>van Duin D</pubmed_authors><pubmed_authors>Fowler VG</pubmed_authors><pubmed_authors>Eilertson B</pubmed_authors><pubmed_authors>Han JH</pubmed_authors><pubmed_authors>Gallagher JC</pubmed_authors><pubmed_authors>Dhar S</pubmed_authors><pubmed_authors>Manca C</pubmed_authors><pubmed_authors>Weston G</pubmed_authors><pubmed_authors>Shrestha R</pubmed_authors><pubmed_authors>Anderson DJ</pubmed_authors><pubmed_authors>Arias CA</pubmed_authors><pubmed_authors>Chambers HF</pubmed_authors><pubmed_authors>Earley M</pubmed_authors><pubmed_authors>Kim A</pubmed_authors><pubmed_authors>Grant M</pubmed_authors><pubmed_authors>Lok JJ</pubmed_authors><pubmed_authors>Jacob JT</pubmed_authors><pubmed_authors>Dai W</pubmed_authors><pubmed_authors>Satlin MJ</pubmed_authors><pubmed_authors>Hujer KM</pubmed_authors><pubmed_authors>Luterbach C</pubmed_authors><pubmed_authors>Kreiswirth BN</pubmed_authors><pubmed_authors>Desai S</pubmed_authors><pubmed_authors>Wong D</pubmed_authors><pubmed_authors>Richter SS</pubmed_authors><pubmed_authors>Salata R</pubmed_authors><pubmed_authors>Abbo LM</pubmed_authors><pubmed_authors>Luterbach CL</pubmed_authors><pubmed_authors>Komarow L</pubmed_authors><pubmed_authors>Perez F</pubmed_authors><pubmed_authors>Banerjee R</pubmed_authors><pubmed_authors>Kalayjian RC</pubmed_authors><pubmed_authors>Marshall SH</pubmed_authors><pubmed_authors>Tran TT</pubmed_authors><pubmed_authors>Garcia-Diaz J</pubmed_authors><pubmed_authors>Panesso D</pubmed_authors><pubmed_authors>Bonomo RA</pubmed_authors><pubmed_authors>Arias R</pubmed_authors><pubmed_authors>Hujer AM</pubmed_authors><pubmed_authors>Wortmann G</pubmed_authors><pubmed_authors>Paterson DL</pubmed_authors><pubmed_authors>Farrell JJ</pubmed_authors><pubmed_authors>Anderson D</pubmed_authors><pubmed_authors>Garner OB</pubmed_authors><pubmed_authors>MDRO Investigators</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characteristics of community-acquired carbapenem-resistant Enterobacterales.</name><description>&lt;h4>Background&lt;/h4>Community-acquired carbapenem-resistant Enterobacterales (CA-CRE) are an important threat.&lt;h4>Methods&lt;/h4>In CRACKLE-2, we defined patients with CA-CRE as admitted from home, without pre-existing conditions, and a positive culture within 48 h of admission. Healthcare-associated CRE (HA-CRE) were those with the lowest likelihood of community acquisition, not admitted from home and cultured &amp;gt;48 h after admission. Specific genetic markers in carbapenemase-producing Klebsiella pneumoniae were evaluated through random forest modelling.&lt;h4>Results&lt;/h4>CA-CRE and HA-CRE were detected in 83 (10%) and 208 (26%) of 807 patients. No significant differences were observed in bacterial species or strain type distribution. K. pneumoniae (204/291, 70%) was the most common CRE species, of these 184/204 (90%) were carbapenemase producers (CPKP). The top three genetic markers in random forest models were kpi_SA15, fimE, and kpfC. Of these, kpi_SA15 (which encodes a chaperone/usher system) was positively associated (OR 3.14, 95% CI 1.13-8.87, P = 0.026), and kpfC negatively associated (OR 0.21, 95% CI 0.05-0.72, P = 0.015) with CA-CPKP.&lt;h4>Conclusions&lt;/h4>Ten percent of CDC-defined CRE were CA. The true proportion of CA-CRE in hospitalized patients is likely lower as patients may have had unrecorded prior healthcare exposure. The kpi_SA15 operon was associated with the CA phenotype.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T11:25:12.933Z</modification><creation>2025-02-19T03:26:14.359Z</creation></dates><accession>S-EPMC9989732</accession><cross_references><pubmed>36179278</pubmed><doi>10.1093/jac/dkac239</doi></cross_references></HashMap>